Skip to main content
Equibles
JANX logo

JANX · Janux Therapeutics, Inc. · Held by Funds

Track JANX — free

Use JANX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research JANX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$17.20 +0.46 (+2.75%) At close · Oct 20
Russell 2000 member Rebalance outlook locked
Market Cap
$1.05B
Shares
61.14M
Volume · Oct 20 869.47K Avg daily vol (3M) 845.94K

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of JANX by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 13.66% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 2.63% 1,609,586
Index ETFs 11.03% 6,741,435
Active ETFs 0.32% 193,151
Active funds 7.45% 4,556,616
Unclassified 0.76% 462,358
All registered funds 22.18% 13,563,146
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding JANX

199 fund positions
Fund Balance Value % of Fund Open
State Street(R) SPDR(R) S&P(R) Biotech ETF 1,928,491 $29,621,622 0.28%
Federated Hermes MDT Small Cap Core Fund 1,374,115 $20,845,325 0.93%
VANGUARD TOTAL STOCK MARKET INDEX FUND 1,263,837 $19,412,536 0.00%
iShares Russell 2000 ETF 1,127,776 $17,322,639 0.02%
VANGUARD EXTENDED MARKET INDEX FUND 552,368 $8,484,372 0.01%
Fidelity Small Cap Index Fund 471,460 $7,152,048 0.02%
VANGUARD STRATEGIC EQUITY FUND 423,646 $6,507,203 0.05%
iShares Russell 2000 Value ETF 405,417 $6,227,205 0.04%
iShares Biotechnology ETF 403,672 $6,200,402 0.07%
Nuveen Quant Small Cap Equity Fund 381,000 $5,779,770 0.14%
Federated Hermes MDT Small Cap Growth Fund 376,425 $5,710,367 0.68%
BlackRock Advantage Small Cap Core Fund 380,620 $5,553,246 0.11%
Bridge Builder Small/Mid Cap Growth Fund 340,741 $5,233,782 0.05%
Fidelity Series Small Cap Core Fund 328,500 $4,983,345 0.32%
VANGUARD EXPLORER FUND 326,362 $4,950,912 0.02%
Fidelity Advisor Biotechnology Fund 320,385 $4,860,240 0.22%
Fidelity Extended Market Index Fund 251,491 $3,669,254 0.01%
Fidelity Blue Chip Growth Fund 230,774 $3,500,842 0.00%
Schwab U.S. Small-Cap ETF 229,332 $3,345,954 0.01%
VANGUARD RUSSELL 2000 INDEX FUND 220,430 $3,216,074 0.02%
Select Biotechnology Portfolio 206,670 $3,015,315 0.06%
NORTH SQUARE DYNAMIC SMALL CAP FUND 162,771 $2,374,829 0.30%
SMALL CAP EQUITY FUND 153,823 $2,362,721 0.23%
Strategic Advisers Fidelity U.S. Total Stock Fund 145,900 $2,128,681 0.00%
iShares Genomics Immunology and Healthcare ETF 124,166 $1,883,598 0.99%
Fidelity Blue Chip Growth ETF 123,298 $1,870,431 0.03%
Dimensional U.S. Small Cap ETF 123,038 $1,866,486 0.01%
VANGUARD STRATEGIC SMALL-CAP EQUITY FUND 118,492 $1,820,037 0.06%
U.S. MICRO CAP PORTFOLIO 119,035 $1,805,761 0.02%
Allspring Common Stock Fund 111,321 $1,709,891 0.25%
VANGUARD HEALTH CARE INDEX FUND 117,140 $1,709,073 0.01%
Schwab Small-Cap Index Fund 105,130 $1,594,822 0.02%
Small Cap Growth Stock Portfolio 102,751 $1,578,255 0.17%
Federated Hermes MDT Small Cap Value Fund f/k/a Federated Hermes Clover Small Value Fund 98,111 $1,506,985 0.86%
Nuveen Quant Small/Mid Cap Equity Fund 98,800 $1,498,796 0.06%
Fidelity Total Market Index Fund 91,364 $1,333,001 0.00%
U.S. SMALL CAP PORTFOLIO 86,270 $1,308,716 0.01%
Master Small Cap Index Series 81,411 $1,250,473 0.02%
Nomura Healthcare Fund 76,601 $1,176,591 0.16%
BlackRock Advantage SMID Cap Fund, Inc. 76,510 $1,175,194 0.12%
HARTFORD SMALL CAP GROWTH HLS FUND 74,279 $1,140,925 0.17%
Fidelity Series Total Market Index Fund 73,740 $1,075,867 0.00%
iShares Core S&P Total U.S. Stock Market ETF 68,269 $1,048,612 0.00%
Strategic Advisers U.S. Total Stock Fund 71,770 $1,047,124 0.00%
Direxion Daily S&P Biotech Bull 3X Shares 65,529 $994,075 0.20%
BlackRock Advantage Small Cap Growth Fund 60,905 $935,501 0.11%
Fidelity Small Cap Value Index Fund 60,191 $924,534 0.04%
Federated Hermes MDT Small Cap Core ETF 62,348 $909,657 0.33%
SMALL COMPANY GROWTH PORTFOLIO 55,497 $852,434 0.05%
iShares U.S. Small-Cap Equity Factor ETF 52,873 $802,083 0.02%
Showing 1–50 of 199 positions
Key facts CIK 1817713 CUSIP 47103J105 13F (30d) 15 filings 15 filers Visit website Investor relations